2-((4-[(2-METHOXYBENZOYL)AMINO]BENZOYL)AMINO)BENZOIC ACID, 95%, 10mg

(S)-tert-Butyl (1-amino-3-phenylpropan-2-yl)carbamate, 95.0%, 500mg

4-Chlorothiazole, 97.0%, 25g

2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)ethanamine, 95.0%, 1g

1-Methylpyrrolidine-2-carboxylic acid hydrochloride, 97.0%, 1g

3-(2,5-Dichloropyrimidin-4-yl)-1-(phenylsulfonyl)-1H-indole, 97%, 5g

2-([1,1'-Biphenyl]-4-ylcarbamoyl)benzoic acid, 95.0%, 1g

4-Nitrobenzyl chloride, min 98%, for synthesis, 50 g, glass packaging

5-Bromo-2-hydroxy-3-methylbenzonitrile, 95.0%, 250mg

Ethyl propionate, 99.0%, 1g

TRANS-TERT-BUTYL 2-(HYDROXYMETHYL)-4-METHYLPYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

4-ethyl-5-(4-isopropylphenyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

Methylhydroxyethyl cellulose, 320-500 mPas, powder, 1 kg, plastic packaging.